The size of the Europe Pyrogen Testing Market was worth USD 147.40 million in 2020. This figure is estimated to be growing at a CAGR of 12.4%, to reach USD 264.44 million by 2025.
A growing number of novel drug launches, increasing demand for pyrogenic testing products in the pharmaceutical and biotechnology industry like Pfizer, Inc., Merck Group, and many more, and medical devices and government assistance towards these industries are expected to propel the market during the forecast period. A growing number of market participants in Europe and the mergers and acquisitions between these companies are expected to boost the market growth.
Unfavorable regulatory policies, reimbursement concerns are some of the major restraints to market growth. Stringent government regulatory frameworks for the drugs and lengthy approval process for the drugs market are expected to obstruct the market growth to a small extent.
This research report on the European Pyrogen Testing Market has been segmented and sub-segmented into the following categories:
By Product:
By Application:
By Test Type:
By Country:
Regionally, Europe is the second-largest market for pyrogen testing accounting for a share of approximately 24%. Within Europe, the United Kingdom is the largest market accounting for roughly 33%. In contrast, Germany is estimated to be the fastest-growing due to the increasing number of chronic diseases.
The UK is leading the European pyrogen testing market with the highest share in the market. Increasing pharmaceutical and biotechnological industries in favor of government support adds fuel to the pyrogen testing market growth. Continuous research and development for the advancements of new drugs are to boost the market.
Germany is expected to witness rapid growth in the pyrogen testing market in this region. The government and other private organizations' enormous investments for research and development activities and favorable government proposals made by Germany are the factors mounting the pyrogen testing market.
Other countries like France, Spain, Italy, and the Rest of Europe are considered to have notable growth in the foreseen years. Moreover, quickly developing healthcare infrastructure, colossal genome pool, and availability of strict minimum guidelines for the development of novel drugs and increasing chronic diseases augments the production of biologics, medical devices, and pharmaceuticals, which further mounts up the market.
Key market participants in the Europe Pyrogen Testing Market profiled in this report are Associates of Cape Cod, Inc., Lonza Group, Merck Kgaa, Thermo Fisher Scientific, Ellab A/S, Genscript, Hyglos GmbH, Charles River Laboratories, Inc., Wako Chemicals USA, Inc., and WUXI Pharmatech (Cayman) Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Kits and Reagents
5.1.2 Services
5.1.3 Instruments
5.2 By Application
5.2.1 Pharmaceutical and Biological Manufacturing
5.2.2 Medical Device Manufacturing
5.2.3 Other Applications
5.3 By Test Type
5.3.1 LAL Tests
5.3.1.1 Chromogenic Tests
5.3.1.2 Turbidimetric Tests
5.3.1.3 Gel Clot Tests
5.3.2 In-Vitro Tests
5.3.3 Rabbit Tests
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Associates of Cape Cod, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Charles River Laboratories, Inc.
8.3 Lonza Group
8.4 Merck Kgaa
8.5 Ellab A/S
8.6 Genscript
8.7 Hyglos GmbH
8.8 Thermo Fisher Scientific, Inc.
8.9 Wako Chemicals USA, Inc.
8.10 WUXI Pharmatech (Cayman) Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
